Skip to content

Clinical trials

Hyperlipidemias trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Country / region: Australia Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20051
20112
20139
20142
20172
20202
20211
20222
20232
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting3
Terminated3
Not yet recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen11
Pfizer4
Novartis Pharmaceuticals3
Chong Kun Dang Pharmaceutical1
Corsera Health1
Eli Lilly and Company1
Kirby Institute1
Mayo Clinic1
Merck Sharp & Dohme LLC1
Monash University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias30
Hypercholesterolemia14
Dyslipidemias8
Cardiovascular Diseases6
Atherosclerosis4
Myocardial Infarction3
Stroke3
HIV Infections2
Hyperlipoproteinemia Type II2
Hypertension2

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.